Summary
The hemodynamic, hormonal, and renal responses to alterations in dietary potassium were studied in normotensive and hypertensive subjects. In a short-term study, nine normotensive and nine hypertensive young men received a normal diet and low potassium, high potassium, and high potassium/low sodium diets for 1 week, each. The long-term effect of potassium supplementation (normal diet plus 96 mmol KCl/d for 8 weeks) was evaluated in 17 patients with essential hypertension. Blood pressure did not change significantly during short-term alterations of potassium intake but decreased during long-term supplementation (from 152.2±3.5/99.6±1.9 mm Hg to 137.4±2.9/89.1±1.4 mm Hg). High dietary potassium induced a significant but transient natriuresis. Plasma potassium concentration was increased during long- but not during short-term high potassium intake. In contrast to plasma renin activity (PRA) and aldosterone, urinary kallikrein was consistently stimulated during long-term potassium supplementation. The plasma concentrations of adrenaline and noradrenaline were significantly higher in hypertensive than in normotensive subjects and were not markedly altered by the dietary changes. It is concluded that long- but not short-term potassium supplementation lowers blood pressure in patients with essential hypertension. The antihypertensive effect may be mediated by potassium-induced natriuresis, by a stimulation of Na-K-ATPase secondary to increased plasma potassium levels, and/or by a modulation of the renin-angiotensin-aldosterone, kallikrein-kinin, and sympathetic nervous systems.
Similar content being viewed by others
Abbreviations
- MAP:
-
mean arterial pressure
- Na-K-ATPase:
-
sodium-potassium ATPase
- PRA:
-
plasma renin activity
References
Meneely GR, Battarbee HD (1976) High sodium-low potassium environment and hypertension. Am J Cardiol 38:768–785
MacGregor GA (1983) Dietary sodium and potassium intake and blood pressure. Lancet I:750–753
Addison WLT (1928) The use of sodium chloride, potassium chloride, sodium bromide, and potassium bromide in cases of arterial hypertension which are amenable to potassium chloride. Can Med Assoc J 18:281–285
McQuarrie I, Thompson WH, Anderson JA (1936) Effects of excessive ingestion of sodium and potassium salts on carbohydrate metabolism and blood pressure in diabetic children. J. Nutr 11:77–101
Priddle WW Observations on the management of hypertension. Can Med Assoc J 25:5–8
MacGregor GA, Smith SJ, Markandu ND, Banks RA, Sagnella GA (1982) Moderate potassium supplementation in essential hypertension. Lancet II:567–570
Iimura O, Kijima T, Kikuchi K, Miyama A, Ando T, Nakao T, Takigami Y (1981) Studies on the hypotensive effect of high potassium intake in patients with essential hypertension. Clin Sci 61:77s-80s
Richards AM, Nichols MG, Espiner EA, Ikram H, Maslowski AH, Hamilton EJ, Wells JE (1984) Blood pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension. Lancet II:757–761
Freis ED (1982) Should mild hypertension be treated? N Engl J Med 307:306–309
Haber E, Koerner T, Page LB, Kliman B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects. J Clin Endocrinol 29:1349–1355
Vetter W, Vetter H, Siegenthaler W (1973) Radioimmunoassay for aldosterone without chromatography. II. Determination of plasma aldosterone. Acta Endocrinol (Kbh) 74:558–567
Vetter W, Vetter H, Siegenthaler W (1973) Radioimmunoassay for aldosterone without chromatography. I. Determination of urinary-18-glucuronide excretion. Acta Endocrinol (Kbh) 74:548–557
Da Prada M, Zürcher G (1976) Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 19:1161–1174
Overlack A, Stumpe KO, Ressel C, Kolloch R, Zywzock W, Krück F (1980) Decreased urinary kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension. Klin Wochenschr 58:37–42
Morgan TO (1982) The effect of potassium and bicarbonate ions on the rise in blood pressure caused by sodium chloride. Clin Sci 63:407s-409s
Holly JMP, Goodwin FJ, Evans SJW, VandenBurg MJ, Ledingham JM (1981) Re-analysis of data in two Lancet papers on the effect of dietary sodium and potassium on blood pressure. Lancet II:1384–1387
Skrabal F, Auböck, J, Hörtnagl H (1981) Low sodium/high potassium diet for prevention of hypertension: probable mechanisms of action. Lancet II:895–900
Young DB, McCaa RE, Pan Y-J, Guyton AC (1976) The natriuretic and hypotensive effects of potassium. Circ Res 38:1184–1189
Bauer JH, Gautner WC (1979) Effect of potassium chloride on plasma renin activity and plasma aldosterone during sodium restriction in normal man. Kidney Int 15:286–293
Brandis M, Keyes J, Windhager EE (1972) Potassium-induced inhibition of proximal tubular fluid reabsorption in rats. Am J Physiol 222:421–427
Kahn M, Bohrer NK (1967) Effect of potassium-induced diuresis on renal concentration and dilution. Am J Physiol 212:1365–1375
Willis T (1976) Pharmaceutica rationalis. Dring, Herper and Leigh, London, p 74
Suzuki H, Kondo K, Saruta T (1981) Effect of potassium chloride on the blood pressure in two-kidney, one clip Goldblatt hypertensive rats. Hypertension 3:566–573
Sealey JE, Clark I, Bull MB, Laragh JH (1970) Potassium balance and the control of renin secretion. J Clin Invest 49:2119–2127
Brunner HR, Baer L, Sealey JE, Ledingham JGG, Laragh JH (1970) The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. J Clin Invest 49:2128–2138
Vander AJ (1970) Direct effects of potassium on renin secretion and renal function. Am J Physiol 219:455–459
Campbell WB, Schmitz JM (1978) Effect of alterations in dietary potassium on the pressor and steroidogenic effects of angiotensins II and III. Endocrinology 103:2098–2104
Overlack A, Stumpe KO, Kolloch R, Ressel C, Krück F (1981) Antihypertensive effect of orally administered glandular kallikrein in essential hypertension. Results of a double blind study. Hypertension 3:I18-I21
Vinci JM, Zusman RM, Izzo JL, Bowden RE, Horwitz D, Pisano JJ, Keiser HR (1979) Human urinary and plasma kinins. Relationship to sodium-retaining steroids and plasma renin activity. Circ Res 44:228–237
Scicli AG, Diaz MA, Carretero OA (1983) Effect of pH and amiloride on the intrarenal formation of kinins. Am J Physiol 245:F198-F203
Horwitz D, Margolius HS, Keiser HR (1978) Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man. J Clin Endocrinol Metab 47:296–299
Marks E, Frech M, Proud D, Keiser HR (1982) Effect of alterations in extracellular fluid volume on urinary kallikrein in the conscious rat. Hypertension 4:625–633
Goldstein DS (1983) Plasma catecholamines and essential hypertension. An analytical review. Hypertension 5:86–99
Masuo K, Ogihara T, Kumahara Y, Yamatadoni A, Wada H (1983) Plasma norepinephrine and dietary sodium intake in normal subjects and patients with essential hypertension. Hypertension 5:767–771
Dietz R, Schömig A, Rascher W, Strasser R, Ganten U, Kübler W (1981) Partial replacement of sodium by potassium in the diet restores impaired noradrenaline inactivation and lowers blood pressure in stroke-prone spontaneously hypertensive rats. Clin Sci 61:69s-71s
Bulpitt CJ, Shipley MJ, Semmence A (1981) Blood pressure and plasma sodium and potassium. Clin Sci 61:85s-87s
Beretta-Piccoli C, Davies DL, Boddy K, Brown JJ, Cumming AMM, East BW, Fraser R, Lever AF, Padfield PL, Semple PF, Robertson JIS, Weidmann P, Williams ED (1982) Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clin Sci 63:257–270
Ueshima H, Tanigaki M, Iida M, Shimamoto T, Konishi M, Komachi Y (1981) Hypertension, salt, and potassium. Lancet I:504
Maxwell MH, Fitzsimmons E, Harrist R, Hotchkiss J, Langford HG, Payne GH, Schneider KA, Varaday P (1983) Baseline laboratory examination characteristics of the hypertensive participants. In: Daugherty SA, Entwisle G (eds) Hypertension and Detection and Follow-Up Program. Baseline characteristics of the enumerated, screened, and hypertensive participants. Hypertension 5:IV133-IV159
Chen W-T, Brace RA, Scott JB, Anderson DK, Haddy FJ (1970) The mechanism of the vasodilator action of potassium. Proc Soc Exp Biol Med 140:820–824
Overbeck HW, Derifield RS, Pamnani MB, Sözen T (1974) Attenuated vasodilator responses to K in essential hypertension. J Clin Invest 53:678–686
Losse H, Wehmeyer H, Wessels F (1960) The water and electrolyte content of erythrocytes in arterial hypertension. Klin Wochenschr 38:393–395
Poston L, Sewell RB, Wikinson SP Richardson PJ, Williams R, Clarkson EM, MacGregor GA, DeWardener HE (1981) Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J 282:847–849
Blaustein MP (1977) Sodium ions, calcium ions, and blood pressure regulation and hypertension: a reassessment and a hypothesis. Am J Physiol 232:C165-C173
Lawrason FD, Alpert E, Mohr FL, McMahon FG (1965) Ulcerative-obstructive lesions of the small intestine. J Am Med Assoc 191:641–644
Author information
Authors and Affiliations
Additional information
The study was supported in part by the Ministerium für Wissenschaft und Forschung, Nordrhein-Westfalen (FA-92/14)
Rights and permissions
About this article
Cite this article
Overlack, A., Stumpe, K.O., Moch, B. et al. Hemodynamic, renal, and hormonal responses to changes in dietary potassium in normotensive and hypertensive man: Long-term antihypertensive effect of potassium supplementation in essential hypertension. Klin Wochenschr 63, 352–360 (1985). https://doi.org/10.1007/BF01731654
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01731654